SCHEMBL133

SCHEMBL133

NNS(=O)(=O)C(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3986623 0.81 CA2 (0.40)
SCHEMBL37874 0.72 CA2 (0.56)
SCHEMBL28511453 0.72 CA2 (0.56)
SCHEMBL4457449 0.72 CA2 (0.56)
SCHEMBL14973911 0.71 CA2 (0.50)
Hydroxyamine SCHEMBL31697696 0.71 CA2 (0.55)
Methylamine SCHEMBL30531790 0.71 CA2 (0.48)
SCHEMBL2901947 0.69 CA2 (0.60)
SCHEMBL23886640 0.69 CA2 (0.53)
SCHEMBL9982903 0.69 CA2 (0.53)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113387771-A Preparation method of chiral fluoroalkyl ternary carbocyclic compound 东北师范大学 2021-09-14 CN claimed
JP-3098772-B2 2000-10-16 JP claimed
EP-0527851-B1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS SEARLE & CO (US) 1998-12-23 EP claimed
EP-0527851-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1993-02-24 EP claimed
WO-1991017148-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-11-14 WO claimed
CN-120505631-A Preparation method for electrochemically synthesizing 3-trifluoromethyl quinoxalinone compound 上海电力大学 2025-08-19 CN disclosed
CN-115872992-B Agrocybenine alkaloid analogue, and preparation method and application thereof 江苏医药职业学院 2024-07-30 CN disclosed
CN-115872992-A Agrocybe alkaloid analogue and preparation method and application thereof 江苏医药职业学院 2023-03-31 CN disclosed
CN-113481524-B Preparation method for electrochemically synthesizing 3-trifluoromethyl coumarin compound 上海电力大学 2022-10-21 CN disclosed
CN-113481524-B Preparation method for electrochemically synthesizing 3-trifluoromethyl coumarin compound 上海电力大学 2022-10-21 CN disclosed
EP-4006921-A2 BIO-ELECTRODE COMPOSITION, BIO-ELECTRODE, METHOD FOR MANUFACTURING BIO-ELECTRODE, AND REACTION COMPOSITE Shin-Etsu Chemical Co., Ltd. (JP) 2022-06-01 EP disclosed
CN-113481524-A Preparation method for electrochemically synthesizing 3-trifluoromethyl coumarin compound 上海电力大学 2021-10-08 CN disclosed
US-5098920-A Hypotensive agents and treatment of congestive heart failure G. D. SEARLE & CO. (US) 1992-03-24 US disclosed
WO-1991017148-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-11-14 WO disclosed
WO-1991000277-A1 SUBSTITUTED IMIDAZOLES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1991-01-10 WO disclosed
WO-1991000281-A2 FUSED-RING ARYL SUBSTITUTED IMIDAZOLES E.I. DU PONT DE NEMOURS AND COMPANY (US) 1991-01-10 WO disclosed
US-4952233-A PRE-AND POSTEMERGENCE BAYER AKTIENGESELLSCHAFT (DE) 1990-08-28 US disclosed
WO-1989006233-A1 ANGIOTENSIN II RECEPTOR BLOCKING IMIDAZOLES AND COMBINATIONS THEREOF WITH DIURETICS AND NSAIDS E.I. DU PONT DE NEMOURS AND COMPANY (US) 1989-07-13 WO disclosed
EP-0302378-A2 Sulphonylaminoguanidino azines BAYER AG (DE) 1989-02-08 EP disclosed
EP-0253310-A2 Angiotensin II receptor blocking imidazoles E.I. DU PONT DE NEMOURS AND COMPANY (US) 1988-01-20 EP disclosed